Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York

Abstract It has been demonstrated that obesity is an independent risk factor for worse outcomes in patients with COVID-19. Our objectives were to investigate which classes of obesity are associated with higher in-hospital mortality and to assess the association between obesity and systemic inflammation. This was a retrospective study which included consecutive hospitalized patients with COVID-19 in a tertiary center. Three thousand five hundred thirty patients were included in this analysis (female sex: 1579, median age: 65 years). The median body mass index (BMI) was 28.8 kg/$ m^{2} $. In the overall cohort, a J-shaped association between BMI and in-hospital mortality was depicted. In the subgroup of men, BMI 35–39.9 kg/$ m^{2} $ and BMI ≥40 kg/$ m^{2} $ were found to have significant association with higher in-hospital mortality, while only BMI ≥40 kg/$ m^{2} $ was found significant in the subgroup of women. No significant association between BMI and IL-6 was noted. Obesity classes II and III in men and obesity class III in women were independently associated with higher in-hospital mortality in patients with COVID-19. The male population with severe obesity was the one that mainly drove this association. No significant association between BMI and IL-6 was noted..

Medienart:

Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

European journal of clinical microbiology & infectious diseases - 40(2021), 9 vom: 06. Mai, Seite 1963-1974

Sprache:

Englisch

Beteiligte Personen:

Guerson-Gil, Arcelia [VerfasserIn]
Palaiodimos, Leonidas [VerfasserIn]
Assa, Andrei [VerfasserIn]
Karamanis, Dimitris [VerfasserIn]
Kokkinidis, Damianos [VerfasserIn]
Chamorro-Pareja, Natalia [VerfasserIn]
Kishore, Preeti [VerfasserIn]
Leider, Jason M. [VerfasserIn]
Brandt, Lawrence J. [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

COVID-19
IL-6
Inflammation
Mortality
Novel coronavirus
Obesity
Observational study
Risk factor
SARS-CoV-2

RVK:

RVK Klassifikation

Anmerkungen:

© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021

doi:

10.1007/s10096-021-04260-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2127080602